Skip to main content

and
Your search also matched 5 preview-only Content is preview-only when you or your institution have not yet subscribed to it.

By making our abstracts and previews universally accessible we help you purchase only the content that is relevant to you.
results, e.g.

Influence of obesity and gender on treatment outcomes in patients with chronic lymphocytic leukemia (CLL) undergoing rituximab-based chemoimmunotherapy

Include preview-only content
  1. Article

    Open Access

    Treatment with idelalisib in patients with chronic lymphocytic leukemia – real world data from the registry of the German CLL Study Group

    Idelalisib in combination with rituximab is an efficacious treatment for patients suffering from chronic lymphocytic leukemia (CLL) with known limitations due to toxicities. However, the benefit after prior B...

    Julia von Tresckow, Nikola Heyl, Sandra Robrecht, Adam Giza in Annals of Hematology (2023)

  2. Article

    Open Access

    Sequential treatment with bendamustine, obinutuzumab (GA101) and Ibrutinib in chronic lymphocytic leukemia (CLL): final results of the CLL2-BIG trial

    Julia von Tresckow, Paula Cramer, Sandra Robrecht, Petra Langerbeins in Leukemia (2022)

  3. Article

    Open Access

    The impact of complex karyotype on the overall survival of patients with relapsed chronic lymphocytic leukemia treated with idelalisib plus rituximab

    Karl-Anton Kreuzer, Richard R. Furman, Stephan Stilgenbauer, Ronald L. Dubowy in Leukemia (2020)

  4. Article

    Open Access

    Clonal dynamics towards the development of venetoclax resistance in chronic lymphocytic leukemia

    Deciphering the evolution of cancer cells under therapeutic pressure is a crucial step to understand the mechanisms that lead to treatment resistance. To this end, we analyzed whole-exome sequencing data of ei...

    Carmen D. Herling, Nima Abedpour, Jonathan Weiss, Anna Schmitt in Nature Communications (2018)